Walleye Capital LLC Alkermes Plc. Call Options Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $21,736 - $25,576	800 New	800 $22,000
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $265,336 - $330,208	-13,600 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $201,818 - $350,902	9,400 Added 223.81%	13,600 $307,000
Q1 2019 May 15, 2019	BUY	$28.4 - $36.49 $119,280 - $153,258	4,200 New	4,200 $153,000

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.9B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.